Primary aldosteronism is the syndrome resulting from the secretion of excessive amounts of aldosterone. It is clinically characterized by a combination of hypertension, hypokalemia,
increased plasma aldosterone, and suppressed plasma renin ( 1 ) .
The wide availability of the sensitive aldosterone assay and of adrenal imaging techniques have made it mucheasier to make the diagnosis. Although the incidence has been reported to be less than 0.5% of all hypertensive patients, it is now one of the most representative causes of surgically curable endocrine hypertension. Therefore, there is no question about the importance of making correct diagnosis. The underlying adrenal disease is usually a unilateral solitary adenoma (APA) and could be cured by unilateral adrena- steroids have been demonstrated to be increased in APAand are useful in differentiating APAfrom IHA. However, these steroids can be measured only in limited laboratories. Advances in CT and MRI relegated adrenal scintigraphy to infrequent use. Yet the method is meritorious in ascertaining the function and localization as well, especially if combined with dexamethasone suppression. Theover all discrimination value between APAand IHA is about 90% (6). Adrenal scintigraphy should be indicated when laterality of the lesion is not identified by CT/MRI, although small and/or functionally weak adenomas maynot be visualized.
Adrenal venoussampling is an invasive but a powerful procedure to ascertain the function as well as the laterality of the lesion. The reported discrimination value is as high as 95% (6) if the blood sampling from both sides of the adrenal vein is accomplished. It should be reminded, however, that the failure rate of collecting blood samples from both sides is as high as 26% (6). The procedure is indicated when the laterality of the lesion is not determined by CT/MRI. Algorithm of determining the subsets and choice of therapy in patients with confirmed primary aldosteronism is shownin Fig. 1 
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CT/MRI, the second line localization technique should be performed in addition to the posture test. Although most of the angiotensin II-responsive cases are IHA, small AP-RAis not completely excluded. If laterality of the hyperfunction is demonstrated by the second line localization technique in cases which are morphologically not unilateral and functionally angiotensin II-unresponsive, small APAis most likely. By contrast, if both sides are equally hyperfunctioning, the definition of PAHmay be used. It is recommended to repeat the hormone assay and first line localization technique every 6 to 12 months when hyperfunction of any side of the adrenal is not identified.
As evident from Fig. 1 , the type of therapy is determined based on the laterality of the lesion: surgery for unilateral lesion and medical therapy for bilateral lesion. However, Matsuda et al (7) reported a case of primary aldosteronism with bilateral multiple adenomas. The report is quite intriguing academically and clinically. First of all, the diagnosis of multiple adenomas was immunohistochemically proved. Enzymesrelated to aldosterone synthesis were found only in the tumor portion but not in the adjacent hyperplastic zona glomerulosa, excluding the diagnosis of IHA. It is suggested that multiple APAis essentially different from IHA with nodularity. Secondarily, bilateral partial adrenalectomy was successfully performed to correct the electrolyte balance and hypertension. The results therefore provide evidence for a possible cure of hyperaldosteronism by surgical therapy even if the lesion is bilateral. However, although preoperative endocrine studies showed the adenoma pattern, the diagnosis of multiple APAwas made histologically after surgery. Wecan not extend the indication of the adrenal surgery to the bilateral lesion unless hyperfunction of the non-tumor portion is preoperatively excluded. The diagnosis and treatment of primary aldosteronism are generally well established. However, we should remember the fact that there are variant forms with morphological and/or functional aberrations. In order to ensure the choice of treatment, further studies to integrate the anatomical and functional data in a larger numberof patients are required.
